Case Reports
Every UPC, EPO and national court decision our fee earners have written up — now filterable by the same 40+ tags they already use to classify each report, plus the court and industry sector behind it.
Artificial Intelligence and Intellectual Property – the Government’s Plans to amend UK law – or not!
BackgroundOn 28 June 2022, the UK Government published its updated conclusions to the consultation it launched in October 2021 which looked at how patents and copyright, which respectively are...
Patents Court affirms power to grant injunctions for pre-grant patents, but refuses injunction for Novartis
Swiss drug-maker, Novartis, sought a preliminary injunction to keep Teva and four other generics off the market for its prescription-only relapse remitting multiple sclerosis treatment, fingolimod,...
High Court refuses Neurim and Flynn interim injunction against Teva in third instalment of melatonin product dispute
In the third chapter of Neurim and Flynn's dispute with generic companies, Mr Justice Mellor refused the Claimants' application for an interim injunction against generic giant, Teva, on the basis...
Not a “FUNTIME” in Court for toy manufacturer after trademark infringement claim in IPEC fails
This judgment concerns a claim for infringement of a UK and EU registered trademark brought in IPEC by Luen Fat Metal and Plastic Manufactory Co Ltd (the "Claimant") against Funko UK, Ltd (the...
Flynn held to be exclusive licensee while both parties at fault on costs in Neurim v Mylan Court of Appeal judgment
On 29 March 2022, the Court of Appeal handed down judgment in relation to appeals made by the Claimants (Neurim and Flynn) on two issues. Overturning Marcus Smith J's decisions, the Court of Appeal,...
Clear all filters
The UPC Newsletter
Get expert insights and the top patent stories delivered straight to your inbox.